ACHIEVE LIFE SCIENCES, INC. (27)
Browse by Contract Category
Contracts
-
Underwriting Agreement dated May 25, 2021
(Filed With SEC on May 25, 2021)
-
Letter of Variation, dated September 28, 2020, by and between Achieve Pharma UK Limited and Richard Stewart
(Filed With SEC on November 12, 2020)
-
Amended and Restated Employment Agreement, dated September 28, 2020, by and between Achieve Life Sciences, Inc. and Cindy Jacobs
(Filed With SEC on November 12, 2020)
-
Form of Indemnification Agreement for Officers and Directors of the Company
(Filed With SEC on November 6, 2019)
-
Office Lease by and between 0846869 B.C. Ltd. and Achieve Life Sciences Technologies Inc., commencing February 1, 2019
(Filed With SEC on March 14, 2019)
-
Form of Underwriters Warrant
(Filed With SEC on November 30, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on November 30, 2020)
-
Amended and Restated Employment Agreement, dated September 28, 2020, by and between Achieve Life Sciences, Inc. and John Bencich
(Filed With SEC on November 12, 2020)
-
Letter of Variation, dated September 28, 2020, by and between Achieve Pharma UK Limited and Anthony Clarke
(Filed With SEC on November 12, 2020)
-
Underwriting Agreement dated August 3, 2020
(Filed With SEC on August 5, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on August 5, 2020)
-
Form of Subscription Agreement
(Filed With SEC on April 30, 2020)
-
Placement Agent Agreement dated as of April 19, 2020, by and between Achieve Life Sciences, Inc. and Paulson Investment Company, LLC
(Filed With SEC on April 30, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on April 30, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on April 30, 2020)
-
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 13, 2020)
-
Amendment No. 1 to Purchase Agreement, by and between Achieve Life Sciences, Inc. and Lincoln Park Capital Fund, LLC. dated as of September 14, 2017
(Filed With SEC on March 13, 2020)
-
Underwriting Agreement dated as of December 17, 2019, by and between Achieve Life Sciences, Inc. and Ladenburg Thalmann & Co. Inc
(Filed With SEC on December 20, 2019)
-
Form of Preferred Stock Certificate
(Filed With SEC on December 20, 2019)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on December 20, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on December 16, 2019)
-
Form of Leak-out Agreement
(Filed With SEC on December 16, 2019)
-
Form of Warrant Offered Hereby
(Filed With SEC on December 16, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on December 2, 2019)
-
At The Market Offering Agreement, dated June 7, 2019, by and between Achieve Life Sciences, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on June 7, 2019)
-
Warrant Exercise Agreement, dated as of May 30, 2019, by and between Achieve Life Sciences, Inc. and Armistice Capital Master Fund, Ltd
(Filed With SEC on June 3, 2019)
-
Common Stock Purchase Warrant, dated as of May 30, 2019
(Filed With SEC on June 3, 2019)
